+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Chemotherapy Induced Nausea Drug"

From
From
Antiemetic Drugs - Global Strategic Business Report - Product Thumbnail Image

Antiemetic Drugs - Global Strategic Business Report

  • Report
  • March 2025
  • 179 Pages
  • Global
From
From
Antiemetics and Antinauseants Market Report 2025 - Product Thumbnail Image

Antiemetics and Antinauseants Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Cancer Supportive Care Market 2024-2028 - Product Thumbnail Image

Cancer Supportive Care Market 2024-2028

  • Report
  • October 2024
  • 188 Pages
  • Global
From
From
Chemotherapy Induced Nausea and Vomiting - Pipeline Insight, 2024 - Product Thumbnail Image

Chemotherapy Induced Nausea and Vomiting - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 60 Pages
  • Global
From
From
Emesis - Pipeline Insight, 2024 - Product Thumbnail Image

Emesis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 65 Pages
  • Global
From
From
From
From
  • 17 Results (Page 1 of 1)
Loading Indicator

Chemotherapy Induced Nausea (CIN) drugs are a type of oncology drug used to treat the nausea and vomiting caused by chemotherapy. CIN drugs are typically administered before, during, or after chemotherapy to reduce the severity of nausea and vomiting. Common CIN drugs include 5-HT3 receptor antagonists, NK-1 receptor antagonists, and corticosteroids. These drugs work by blocking the action of serotonin and other chemicals in the brain that cause nausea and vomiting. CIN drugs are an important part of cancer treatment, as they can help reduce the side effects of chemotherapy and improve the quality of life for cancer patients. CIN drugs are available in both oral and intravenous forms, and are often used in combination with other anti-nausea medications. Companies in the CIN drug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more